Cyberonics eager to offer upgraded epilepsy care A more innovative form of its nerve-stimulating device awaits U.S. OK

Cyberonics officials on Thursday said the Houston-based company could begin offering a more sophisticated version of its nerve-stimulating device to treat U.S. epilepsy patients as early as next year, pending federal approval.

To continue reading this story, you will need to be a digital subscriber to HoustonChronicle.com. Houston Chronicle subscribers have FREE access to all premium digital products.

By logging in, you agree to the Terms and Conditions and Privacy Policy.